These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 20430401)

  • 21. Growth factor therapy to the damaged inner ear: clinical prospects.
    Malgrange B; Rigo JM; Van de Water TR; Staecker H; Moonen G; Lefebvre PP
    Int J Pediatr Otorhinolaryngol; 1999 Oct; 49 Suppl 1():S19-25. PubMed ID: 10577769
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Three-dimensional fluid-attenuated inversion recovery magnetic resonance imaging investigation of inner ear disturbances in cases of middle ear cholesteatoma with labyrinthine fistula.
    Sone M; Mizuno T; Sugiura M; Naganawa S; Nakashima T
    Otol Neurotol; 2007 Dec; 28(8):1029-33. PubMed ID: 17921909
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Stem-cell-based approaches for treating inner ear diseases].
    Senn P; Heller S
    HNO; 2008 Jan; 56(1):21-6. PubMed ID: 18231694
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mammalian auditory hair cell regeneration/repair and protection: a review and future directions.
    Feghali JG; Lefebvre PP; Staecker H; Kopke R; Frenz DA; Malgrange B; Liu W; Moonen G; Ruben RJ; Van de Water TR
    Ear Nose Throat J; 1998 Apr; 77(4):276, 280, 282-5. PubMed ID: 9581394
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Advances in translational inner ear stem cell research.
    Warnecke A; Mellott AJ; Römer A; Lenarz T; Staecker H
    Hear Res; 2017 Sep; 353():76-86. PubMed ID: 28571616
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The role of the spiral ganglion neurons in cochlear implants. Today and in future regenerative inner ear treatment].
    Euteneuer S; Hansen S; Ryan AF
    HNO; 2008 Apr; 56(4):457-60. PubMed ID: 18351308
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gene transfer in inner ear cells: a challenging race.
    Sacheli R; Delacroix L; Vandenackerveken P; Nguyen L; Malgrange B
    Gene Ther; 2013 Mar; 20(3):237-47. PubMed ID: 22739386
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Controlled drug release to the inner ear: Concepts, materials, mechanisms, and performance.
    Mäder K; Lehner E; Liebau A; Plontke SK
    Hear Res; 2018 Oct; 368():49-66. PubMed ID: 29576310
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fistulae in the membranous labyrinth.
    Kimura RS
    Ann Otol Rhinol Laryngol Suppl; 1984; 112():36-43. PubMed ID: 6431879
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetic principles in the inner ear: Influence of drug properties on intratympanic applications.
    Salt AN; Plontke SK
    Hear Res; 2018 Oct; 368():28-40. PubMed ID: 29551306
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Labyrinth and diabetes: parallel clinical study in 2 groups of patients with labyrinth disease and diabetes].
    Catalano GB; Madonia HT; Garozzo A; di Mauro A; Vancheri M
    Acta Otorhinolaryngol Belg; 1981; 35(1):43-9. PubMed ID: 7293766
    [No Abstract]   [Full Text] [Related]  

  • 32. The role of micro-noise trauma in the etiology of aging-related changes in the inner ear.
    Bohne BA; Maghami EG; Bahadori RS; Harding GW
    Hear Res; 1998 Oct; 124(1-2):132-45. PubMed ID: 9822911
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathology and pathophysiology of idiopathic sudden sensorineural hearing loss.
    Merchant SN; Adams JC; Nadol JB
    Otol Neurotol; 2005 Mar; 26(2):151-60. PubMed ID: 15793397
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adeno-associated virus gene replacement for recessive inner ear dysfunction: Progress and challenges.
    Askew C; Chien WW
    Hear Res; 2020 Sep; 394():107947. PubMed ID: 32247629
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nanotechnology and the treatment of inner ear diseases.
    Poe DS; Pyykkö I
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2011; 3(2):212-221. PubMed ID: 25363748
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of gene therapy for inner ear disease: Using bilateral vestibular hypofunction as a vehicle for translational research.
    Staecker H; Praetorius M; Brough DE
    Hear Res; 2011 Jun; 276(1-2):44-51. PubMed ID: 21251965
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inner ear drug delivery for auditory applications.
    Swan EE; Mescher MJ; Sewell WF; Tao SL; Borenstein JT
    Adv Drug Deliv Rev; 2008 Dec; 60(15):1583-99. PubMed ID: 18848590
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Corticosteroid therapy in stapedectomy. An experimental study.
    Hendershot EL
    Laryngoscope; 1968 Nov; 78(11):1879-903. PubMed ID: 4972662
    [No Abstract]   [Full Text] [Related]  

  • 39. [Acute diseases of the inner ear].
    van der Baan S; Feenstra L
    Ned Tijdschr Geneeskd; 1987 Apr; 131(17):717-9. PubMed ID: 3587386
    [No Abstract]   [Full Text] [Related]  

  • 40. [Research progress in targeted delivery of inner ear using nanocarriers].
    Chen Y; Zhang H
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2024 Apr; 38(4):348-353. PubMed ID: 38563182
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.